Matrix Vesicles: Role in Bone Mineralization and Potential Use as Therapeutics.
作者信息
Ansari Sana, de Wildt Bregje W M, Vis Michelle A M, de Korte Carolina E, Ito Keita, Hofmann Sandra, Yuana Yuana
机构信息
Orthopaedic Biomechanics, Department of Biomedical Engineering, TU Eindhoven, 5600 MB Eindhoven, The Netherlands.
Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands.
出版信息
Pharmaceuticals (Basel). 2021 Mar 24;14(4):289. doi: 10.3390/ph14040289.
Bone is a complex organ maintained by three main cell types: osteoblasts, osteoclasts, and osteocytes. During bone formation, osteoblasts deposit a mineralized organic matrix. Evidence shows that bone cells release extracellular vesicles (EVs): nano-sized bilayer vesicles, which are involved in intercellular communication by delivering their cargoes through protein-ligand interactions or fusion to the plasma membrane of the recipient cell. Osteoblasts shed a subset of EVs known as matrix vesicles (MtVs), which contain phosphatases, calcium, and inorganic phosphate. These vesicles are believed to have a major role in matrix mineralization, and they feature bone-targeting and osteo-inductive properties. Understanding their contribution in bone formation and mineralization could help to target bone pathologies or bone regeneration using novel approaches such as stimulating MtV secretion in vivo, or the administration of in vitro or biomimetically produced MtVs. This review attempts to discuss the role of MtVs in biomineralization and their potential application for bone pathologies and bone regeneration.